For 100 years, C. R. Bard, Inc. has committed its resources to creating innovative products and services that meet the needs of healthcare providers and patients. Today, Bard is a worldwide leader in products that focus on Disease State Management in...
For 100 years, C. R. Bard, Inc. has committed its resources to creating innovative products and services that meet the needs of healthcare providers and patients. Today, Bard is a worldwide leader in products that focus on Disease State Management in three key areas: Vascular, Urology and Oncology. To complement these areas, Bard has a complete line of advanced Surgical Specialty Products and Services.C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialty products.
Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities.
Bard pioneered the development of single-patient-use medical products for hospital procedures; today Bard is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall costs.Research & Development
The blending of carefully selected internal development activities, complemented by highly focused associations with innovative development partners and medical specialists.
In order to fulfill our goal of providing a constant supply of new, innovative products to improve clinical outcomes, be responsive to the needs of health care practitioners and sensitive to issues of patient comfort, while controlling the costs of that care, we utilize the skill and innovative capabilities of our research and development organization, supplemented by a significant program to identify, acquire and develop important new technologies and products which were conceived outside the Corporation.
Click here for information on the Idea Generation Process
Bard leverages its capabilities in product development, and its demonstrated ability to commercialize products in a timely fashion to attract suitable partners from the academic, practitioner and industrial communities to insure that products and product development opportunities from other organizations will properly supplement its internal development efforts.
One of our most critical components of revenue growth strategy is our ability to identify, manufacture and market innovative, technology-based solutions to treat disease and disability. Bard's significant increase in R&D investment in recent years- from million in 2001 to 4 million in 2005 - is a measure of our commitment to innovation and evidence of our ability to execute growth strategy.
In recent years, our increased focus on R&D has yielded some significant results. We have strengthened our infrastructure- creating an interactive R&D Council to share diverse experiences, and leverage ideas and best practices among our divisions. The council has designed a portfolio management tool to measure improvement and effectiveness in our product development process, and as a result, our product development pipeline has increased to more than 150 active projects. C. R. Bard has seven business units that support a broad product offering in the fields of Vascular, Urology, Oncology, and Surgical Specialty. Please use the left navigation to find out more about our business units, disease state management, and categories of Bard's U.S. product offerings. In addition, you will find information on the reimbursement, e-commerce, and OEM areas of our business.Reimbursement
Reimbursement is an increasingly important consideration in the development and marketing of medical devices and Bard recognizes its critical importance to the customers who use our products.
As the largest single healthcare insurer in the U.S., Medicare has a profound influence on the healthcare market. The Centers for Medicare and Medicaid Services (CMS) formulates national and local coverage policy and sets reimbursement rates for facility and physician providers. As for commercial payers, managed care organizations cover approximately 200 million individuals in the U.S. and these payers often follow the lead set by CMS when determining their own coverage and payment guidelines.
Regardless of the payer, three basic steps must occur for the product or procedure to be considered reimbursable.
First, payers must consider the product or procedure as a part of a covered set of benefits
Second, a billing code must exist or be established to identify the product or procedure
Finally, payment must be assigned for the code
In general, the complexity and integration of these processes are significant challenges for manufacturers seeking to bring products to market. Bard's Corporate Reimbursement Department seeks to work with decision-makers including government agencies, specialty medical societies and public and private payers to insure our products are appropriately reimbursed in the marketplace.
For many Bard products, considerations necessary to establish reimbursement are already established as their use falls under existing categories of care such as those for inpatient hospital services or outpatient and ambulatory care settings. Under such systems, a prospective payment bundle (DRG or APC) is set to include costs of services and products needed to provide a specific procedure or episode of care. Bard continually monitors the sufficiency of these reimbursements and takes actions to insure they are adequate and appropriate. Bard E-Quest™ E-Commerce Solutions
Many customers and trading partners in health care have recognized that e-commerce can be a valuable tool in reducing costs and increasing the effectiveness of the healthcare supply chain. Bard E-Quest™ solutions make it easy to establish a connection to quality products from Bard.
C. R. Bard, Inc. currently offers Bard E-Quest™ e-commerce solutions for:
Bard will continue to expand our e-commerce capabilities to provide item master updates, contract notification, electronic funds transfer, ship notifications, and other features that will continue to add to the value of e-commerce.